Biotech News
Vor Bio To Participate in 2026 Jefferies Global Healthcare Conference
Vor Bio (Nasdaq: VOR), a clinical-stage biotechnology company transforming the treatment of autoimmune diseases, today announced that management will participate in a fireside chat at the Jefferies Global Healthcare Conference in London, United Kingdom.
